Prohibits procurement of opioid antidotes from certain entities.
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed General Assembly
- To Governor
- Became Law
Overview
This bill aims to ensure that New Jersey purchases opioid overdose medications, like naloxone, only from pharmaceutical manufacturers and distributors that were not involved in legal settlements related to the opioid crisis. It directs state agencies to exclude companies that participated in fueling the opioid epidemic from bidding on contracts for these vital medications. The bill prioritizes purchasing from unaffected manufacturers and distributors to prevent further reliance on companies with a history of contributing to the opioid problem.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Introduced
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours